Rajesh Krishna, PhD, FAAPS

Senior Director at Certara Strategic Consulting

United States of America

Rajesh Krishna, PhD, FAAPS is currently Senior Director at Certara Strategic Consulting.  Prior to joining Certara, Rajesh was a distinguished scientist and executive director at Merck, and prior to joining Merck, was at Aventis (later Sanofi) and at Bristol-Myers Squibb.  Rajesh has contributed to the clinical pharmacology components of over 40 INDs; to the design, development, execution, and reporting of over 200 Phase 1/1b studies; and to the worldwide registration of more than 10 new molecular entities, spanning many therapeutic areas.  Rajesh received Ph.D in pharmaceutical sciences from the University of British Columbia, Canada and an MBA from Warwick Business School, UK.  He is an elected fellow of the American Association of Pharmaceutical Scientists, a member of the editorial board of the Journal of Clinical Pharmacology and has published about 90 peer-reviewed publications and edited or co-edited 4 books on new drug development.  He is the author of Raj’s clinical pharmacology blogs (https://www.certara.com/rajs-corner-blog-roundup/).